Thyroid function and life expectancy with and without noncommunicable diseases: A population-based study

Abstract

Background

Variations in thyroid function within reference ranges are associated with increased risk of diseases and death. However, the impact of thyroid function on life expectancy (LE) with and without noncommunicable diseases (NCDs) remains unknown. We therefore aimed to investigate the association of thyroid function with total LE and LE with and without NCD among euthyroid individuals.

Methods and findings

The study was embedded in the Rotterdam Study, a prospective population-based study carried out in the Netherlands. In total, 7,644 participants without known thyroid disease and with thyroid-stimulating hormone (TSH) and free thyroxine (FT ₄) levels within reference ranges were eligible. NCDs were defined as presence of cardiovascular disease, diabetes mellitus type 2, or cancer. We used the demographic tool of multistate life tables to calculate LE estimates at the age of 50 years, using prevalence, incidence rates, and hazard ratios for three transitions (healthy to NCD, healthy to death, and NCD to death). The total LE and LE with and without NCD among TSH and FT ₄ tertiles were calculated separately in men and women. Analyses were adjusted for sociodemographic and cardiovascular risk factors. The mean (standard deviation) age of the participants was 64.5 (9.7) years, and 52.3% were women. Over a median follow-up of 8 years (interquartile range 2.7–9.9 years), 1,396 incident NCD events and 1,422 deaths occurred. Compared with those in the lowest TSH tertile, men and women in the highest TSH tertile were expected to live 1.5 years (95% confidence interval [CI] 0.8–2.3, p < 0.001) and 1.5 years (CI 0.8–2.2, p < 0.001) longer, respectively, of which 1.4 years (CI 0.5–2.3, p = 0.002) and 1.3 years (CI 0.3–2.1, p = 0.004) with NCD. Compared with those in the lowest FT ₄ tertile, the difference in LE for men and women in the highest FT ₄ tertile was −3.7 years (CI −5.1 to −2.2, p < 0.001) and −3.3 years (CI −4.7 to −1.9, p < 0.001), respectively, of which −1.8 years (CI −3.1 to −0.7, p = 0.003) and −2.0 years (CI −3.4 to −0.7, p = 0.003) without NCD. A limitation of the study is the observational design. Thus, the possibility of residual confounding cannot be entirely ruled out.

Conclusions

In this study, we found that people with low–normal thyroid function (i.e., highest tertile of TSH and lowest tertile of FT ₄ reference ranges) are expected to live more years with and without NCD than those with high–normal thyroid function (i.e., lowest tertile of TSH and highest tertile of FT ₄ reference ranges). These findings provide support for a re-evaluation of the current reference ranges of thyroid function.

Abstract

Arjola Bano and colleagues reveal that people with a lower-normal level of thyroid function are more likely to live longer and without NCDs.

Author summary

Why was this study done?

• Thyroid dysfunction is an important public health problem that is associated with an increased risk of noncommunicable diseases (NCDs), such as cardiovascular diseases, diabetes, and cancer. The diagnosis and treatment of thyroid dysfunction is based on thyrotropin and free thyroxine measurements.

• Accumulating evidence has suggested that the clinical consequences of thyroid dysfunction are extended even within the reference ranges of thyrotropin and free thyroxine levels.

• However, the impact of thyroid function on life expectancy with and without NCD remains unknown.

What did the researchers do and find?

• We performed a large prospective population-based cohort study within the framework of the Rotterdam Study.

• We investigated the association of thyroid function with life expectancy with and without NCD among euthyroid individuals.

• We found that individuals with low–normal thyroid function live up to 3.7 years longer overall, of which up to 1.9 years longer with NCD, than individuals with high–normal thyroid function.

What do these findings mean?

• Our study provides novel insights about the qualitative and quantitative impact of thyroid function on life expectancy.

• Our findings provide support for a re-evaluation of the reference ranges of thyroid function in middle-aged and older adults. This can have further implications on the diagnosis and treatment of thyroid disease.